Protagenic Therapeutics, Inc. is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat several stress related disorders. Protagenic Therapeutics is building a TCAP platform to address many neuropsychiatric disorders and other neurodegenerative diseases that are impacted by the stress response system of the brain.